Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saffron and Reduced Fasting Blood Glucose Levels

Research synthesisModerate evidenceSmall effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies (3 meta-analyses and 1 RCT), 3 reported beneficial effects of saffron supplementation on reducing fasting blood glucose (FBG), with predominantly small effect sizes. The most studied population was clinical (metabolic syndrome, type 2 diabetes, prediabetes), and the median study duration was 84 days (12 weeks), suggesting effects are typically observed at 12 weeks. The only study reporting a dose used 200 mg/day.

  • Effective dose range: 200 mg/day
  • Studied populations: people with metabolic syndrome, type 2 diabetes, or prediabetes

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). One meta-analysis did not find a significant effect for saffron specifically (the significant finding was pooled across multiple herbs/spices), adding some inconsistency. The dose was reported in only one study, limiting dose-response conclusions.

Generated Jul 18, 2026
Doses used in studies
  • mg/day: 200 (median 200, IQR 200200) 1 study
Time to effect
Median: 2.8 months · IQR 2.8 months2.8 months · Range 2.8 months2.8 months — Reported in 1 of 4 studies
4 of 4 papers
Back to top